Interleukin-8 (IL-8) and intercellular adhesion molecule 1 (ICAM-1) are known NFκB targets and are both pro-inflammatory molecules also known to promote hepatic inflammation in NAFLD [37,38]. Here, CXCL8 is linked to metabolic dysfunction-associated steatotic liver disease.